We are live on
!
Find out more
AstraZeneca
AZN
AZN
518 hedge funds and large institutions have $13.9B invested in AstraZeneca in 2018 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 166 increasing their positions, 167 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
48% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 40
45% more call options, than puts
Call options by funds: $171M | Put options by funds: $118M
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
3% more funds holding
Funds holding: 502 → 518 (+16)
4% more capital invested
Capital invested by funds: $13.4B → $13.9B (+$525M)
0.47% more ownership
Funds ownership: 15.21% → 15.68% (+0.47%)
1% less repeat investments, than reductions
Existing positions increased: 166 | Existing positions reduced: 167
Holders
518
Holders Change
+16
Holders Change %
+3.19%
% of All Funds
11.87%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.16%
New
59
Increased
166
Reduced
167
Closed
40
Calls
$171M
Puts
$118M
Net Calls
+$53.4M
Net Calls Change
-$5.35M
Top Buyers
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$101M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$81.8M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$70.2M |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$69.3M |
| 5 |
HP
Holowesko Partners
Nassau,
Bahamas
|
-$50.9M |
